Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 3.827
AS - Asia 3.074
EU - Europa 3.032
SA - Sud America 685
AF - Africa 61
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.700
Nazione #
US - Stati Uniti d'America 3.737
SG - Singapore 1.526
DE - Germania 865
CN - Cina 863
BR - Brasile 594
SE - Svezia 531
UA - Ucraina 515
IE - Irlanda 219
IT - Italia 216
FR - Francia 212
ID - Indonesia 133
FI - Finlandia 126
GB - Regno Unito 118
VN - Vietnam 114
IN - India 113
RU - Federazione Russa 91
TR - Turchia 47
IQ - Iraq 35
JP - Giappone 35
AR - Argentina 34
CA - Canada 34
HK - Hong Kong 33
BD - Bangladesh 32
MX - Messico 31
PL - Polonia 29
ZA - Sudafrica 23
BE - Belgio 22
PK - Pakistan 21
SA - Arabia Saudita 20
NL - Olanda 19
AU - Australia 16
CO - Colombia 14
ES - Italia 12
KR - Corea 11
IR - Iran 10
CH - Svizzera 9
CL - Cile 8
EC - Ecuador 8
PY - Paraguay 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
MA - Marocco 7
UZ - Uzbekistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PH - Filippine 6
DZ - Algeria 5
JO - Giordania 5
LB - Libano 5
NP - Nepal 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
DK - Danimarca 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
RO - Romania 4
AT - Austria 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
MM - Myanmar 3
MN - Mongolia 3
RS - Serbia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
KW - Kuwait 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RE - Reunion 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BM - Bermuda 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
Totale 10.687
Città #
Singapore 605
Chandler 515
Ashburn 481
Jacksonville 264
San Mateo 214
Dublin 211
Beijing 189
Wilmington 125
Jakarta 124
Nanjing 111
Ann Arbor 108
Hefei 89
Lawrence 89
Boston 88
Cattolica 73
Dearborn 69
Los Angeles 67
Moscow 63
Houston 60
New York 58
Woodbridge 52
Fairfield 47
Redwood City 47
Boardman 45
Seattle 44
São Paulo 41
Hanoi 40
Buffalo 38
Dallas 38
Detroit 37
Marseille 34
Mountain View 34
Kent 33
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
Shenyang 32
Munich 31
University Park 31
Chicago 29
Hebei 29
Rio de Janeiro 28
Frankfurt am Main 27
Hong Kong 27
Ho Chi Minh City 26
Helsinki 23
Milan 23
Princeton 23
Shanghai 23
Izmir 22
Brussels 20
Bremen 19
Cambridge 19
Norwalk 19
Jiaxing 18
Changsha 17
Guangzhou 17
Rome 17
Washington 16
Tianjin 15
Tokyo 15
Baghdad 14
Brooklyn 14
Jinan 14
Kraków 14
Santa Clara 14
Zhengzhou 14
Belo Horizonte 13
London 13
Fremont 12
Pune 12
Johannesburg 11
Ankara 10
Brasília 10
Düsseldorf 10
Simi Valley 10
Curitiba 9
Denver 9
Dhaka 9
Jeddah 9
Kunming 9
Leawood 9
Nuremberg 9
Philadelphia 9
Porto Alegre 9
Stockholm 9
Warsaw 9
Busto Arsizio 8
Lahore 8
Phoenix 8
Poplar 8
Seoul 8
Atlanta 7
Bareggio 7
Council Bluffs 7
Encino 7
Fortaleza 7
Indiana 7
Paris 7
Totale 5.201
Nome #
Can vitamin a mediate immunity and inflammation? 159
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 153
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 150
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 149
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 145
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 145
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 143
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 139
Role of vitamins D, E and C in immunity and inflammation. 135
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 135
Reflux symptoms in wind instrument players. 130
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 128
The immune response to tumors as a tool toward immunotherapy 126
Impact of mast cells in rejection of allografts 126
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 125
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 124
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 124
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 123
IL-32: a newly-discovered proinflammatory cytokine 120
Interleukin-6 in Rheumatoid Arthritis 120
Third-line rescue therapy for Helicobacter pylori infection 119
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 118
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 116
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 114
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 114
New insights on the role of T-cels in the pathogenesis of Celiac Disease 112
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 111
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 110
New insights on the role of T cells in the pathogenesis of celiac disease. 108
Third-line rescue therapy for Helicobacter pylori infection. 107
TLR2: a crossroads between infections and autoimmunity? 107
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 107
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 107
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 106
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 102
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 101
Luteolin inhibits mast cell-mediated allergic inflammation. 101
Current Challenges in Immunology 101
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 99
Impact of IL-18 on inflammation 99
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 96
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 95
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 95
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 95
Impairment of recent thymic emigrants in HCV infection. 93
Mast cell involvement in rheumatoid arthritis. 93
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 93
The impact of biological agents interfering with receptor/ligand binding in the immune system. 92
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 91
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 91
High prevalence of hyperplastic colonic polyps in acromegalic subjects 90
Role of mast cells in innate and adaptive immunity. 90
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 90
Activity of caffeic acid derivatives against Candida albicans biofilm 88
VEGF, substance P and stress, new aspects: a revisited study. 88
Impact of Fungi on Immune Responses 88
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 87
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 87
TLR2: a crossroads between infections and autoimmunity? 87
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 86
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 86
Strategies to overcome obstacles to successful immunotherapy of melanoma. 86
Interrelationship between IL-3 and mast cells 86
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 83
Strategies to overcome obstacles to successful immunotherapy of melanoma 83
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 83
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 82
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 81
Abnormal synthesis of IgA in coeliac disease and related disorderd 81
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 80
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 80
Vitamins and mast cells. 79
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 79
Nerve growth factor interactions with mast cells 79
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 78
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 78
IL-31 a Th2 cytokine involved in immunity and inflammation. 78
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 78
Involvment of central immunity in uncomplicated diverticular disease. 77
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 76
Active thymopoiesis in idiopathic chronic pancreatitis 76
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 75
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 74
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 73
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 72
Impact of mast cells on the skin. 72
Impact of IL -9 and IL-33 in mast cells 72
Nerve growth factor interactions with mast cells 71
Nutrition and cancer prevention 71
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 69
Epatite da farmaci 68
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 67
IL-36 receptor antagonist with special emphasis on IL-38. 67
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 66
Psychological stress and vitamins 66
Interrelationship between IL-3 and mast cells 66
VEGF, substance P and stress, new aspects: a revisited study 65
IgE generation and mast cell activation 65
HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease 64
Totale 9.730
Categoria #
all - tutte 48.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021576 0 0 0 0 0 76 132 24 114 16 186 28
2021/2022881 65 128 15 63 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.646 46 72 146 38 107 51 18 112 298 114 325 319
2025/20262.401 702 132 301 411 697 158 0 0 0 0 0 0
Totale 10.763